Device Technologies has announced the appointment of Heath Priestly as Chief Executive Officer, succeeding Michael Trevaskis, who will transition to the role of Executive Vice Chairman with a focus on mergers, acquisitions, and business development.

Michael Trevaskis served as CEO for over nine years, during which time he has built a diverse, resilient organisation that partners closely with the healthcare industry to deliver innovative technologies that enhance clinical outcomes and create meaningful impact for patients. Under his leadership, Device Technologies has worked hand-in-hand with customers to understand their challenges and bring the most innovative technologies available worldwide to the markets it serves.

“It has been the privilege of my career to lead Device Technologies” said Michael Trevaskis. “Together we have achieved remarkable progress, and I am proud of the culture we have built, one defined by collaboration, seeking innovation, practicing good business, and belief in each other. I am confident Device Technologies’ best days lie ahead.”

Heath Priestly, who has been with Device Technologies for over 24 years, has deep experience across multiple roles within the organisation. He has a strong commitment to advancing customer experience, driving transformation, and unlocking the company’s full potential for positive healthcare impact.

“I am honored to step into the role of CEO and continue the work of advancing the vision we have for Device Technologies Group,” said Heath Priestly. “Having worked across many areas of the business, I have seen first-hand the talent and dedication of our people. I am passionate about building on our strengths and ensuring we fulfil our potential for the patients and communities we serve.”

The leadership transition highlights Device Technologies’ commitment to continuity, innovation, and long-term growth. Michael Trevaskis’ contribution, within the organisation and across the broader healthcare industry, has been marked by a focus on meaningful outcomes, strong relationships, and collaboration with customers. These qualities have advanced the company’s vision for the future of healthcare and solidified its reputation as a trusted partner in care. With this foundation, Device Technologies is poised to accelerate innovation, expand its impact, and continue leading in medical device excellence.